{"id":"W4399960956","doi":"10.1530/erc-23-0337","title":"Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Ipsen; Sanofi; Exelixis; Advanced Accelerator Applications; Gilead Sciences; Eisai; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Lanreotide; Medicine; Clinical endpoint; Placebo; Internal medicine; Gastroenterology; Neuroendocrine tumors; Phases of clinical research; Surgery; Randomized controlled trial; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007957251,0.0004268442,0.000697495,0.0002417393,0.0001067998,0.00003792679,0.0002057044,0.0000116989,0.0007904252],"category_scores_gemma":[0.00006029639,0.0002348584,0.0001556949,0.0008796869,0.000202277,0.0001721707,0.00006890295,0.0004790165,0.00005750381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003400382,"about_ca_system_score_gemma":0.0004243991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009835865,"about_ca_topic_score_gemma":0.0003858176,"domain_scores_codex":[0.9971871,0.0001319072,0.0005617924,0.0006722361,0.0007459763,0.0007009605],"domain_scores_gemma":[0.9985318,0.0002326659,0.0001282859,0.0007318605,0.0001335546,0.0002418626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09074453,0.02315474,0.0565686,0.002822711,0.01698462,0.3236638,0.008443309,0.0141157,0.07123152,0.002386636,0.02290571,0.3669782],"study_design_scores_gemma":[0.1429712,0.06220149,0.006429511,0.002093188,0.002887194,0.01652882,0.003225357,0.004476567,0.1438441,0.0001907534,0.6139105,0.001241302],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751241,0.012335,0.000009072294,0.005490961,0.0003964131,0.003351863,0.00005984615,0.0003746341,0.002858112],"genre_scores_gemma":[0.9788407,0.002591536,0.0001119648,0.00008195776,0.000150379,0.0009265644,0.00003288243,0.0001039734,0.01716003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5910048,"threshold_uncertainty_score":0.9577249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01840343130983612,"score_gpt":0.3733725241638662,"score_spread":0.3549690928540301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}